NIH RADx
Overview
The NIH Rapid Acceleration of Diagnostics (RADx) initiative was launched to speed innovation in the development, commercialization, and implementation of technologies for COVID-19 testing. It is a national call for scientists and organizations to bring their innovative ideas for new COVID-19 testing approaches and strategies, aiming to make millions of tests per week available to Americans.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Amydis, Inc. | Mar 2026 | Grant | Co-investor |
| Physical Sciences | Feb 2026 | Grant | Lead |
| EMBioSys | Nov 2025 | Grant | Co-investor |
| GreenMark Biomedical Inc. | Nov 2025 | Grant | Co-investor |
| Rendever | Nov 2025 | Grant | Lead |
Key People
Chi-Ping Day
Founder, NIH Interspecific Modeling Interest Group (ISMIG)
Nananda Col
Founder, Shared Decision Making Resources
Bridget Lampert
Managing Director, NIH Oxford Cambridge Scholars Program And MDPhD Program
Kristi M. Porter
Managing Director, NIH Oxford-Cambridge Scholars Program
Kris Walker
Clinical Research Partner
Cari A. Tvinnereim
Director - UX Strategy
Christian Grillon
Principal Investigator
Dan Benjamini
Principal Investigator. Chief, Multiscale Imaging And Integrative Biophysics Unit, NIA
David McDermott
Principal Investigator
Dhruba Chattoraj
Sr. Principal Investigator
Dianne Thorpe
Principal Administrative Officer
Doris Wu
Principal Investigator
Emmanouil Maragkakis
Stadtman Principal Investigator & Chief Of Computational Genomics Unit
Gene Teveler
Principal Enterprise Architect
Ghazala Ashfaq
Principal
Jian Liu
Principal Investigator
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
